Dendrogenix

Belgium
Ligny, Wallonia, Belgium, 4000

Company profile

Dendrogenix company profile

Dendrogenix is a biopharmaceutical company that focuses on developing innovative drugs based on Dendrogenins. These small molecules are designed to address high unmet medical needs, particularly in the areas of deafness and cancer. The company aims to create first-in-class molecules to provide new therapeutic options for patients suffering from these conditions. Dendrogenix's research and development efforts are centered on leveraging the unique properties of Dendrogenins to develop effective treatments for hearing loss and neurological diseases.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Postal code
4000
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Founders
1

Founders and investors

Founders

Emile Loria